UFPT
UFP TECHNOLOGIES INC
NASDAQ · Healthcare · Medical - Devices · US
$293.25
+0.54%Year over year
Reported trailing growth
- Revenue
- +7.3%
- EBITDA
- +3.1%
- EBIT
- +2.0%
- EPS
- +7.2%
- Free cash flow
- -15.3%
- Operating cash flow
- -14.1%
Forward estimates
Based on analyst estimates
- Revenue
- +8.6%
- EBITDA
- +10.3%
- EPS
- +11.4%
Three-year CAGR
- Revenue
- +19.4%
- EBITDA
- +18.3%
- EBIT
- +18.6%
- Net income
- +17.8%
- EPS
- +17.1%
- Free cash flow
- +171.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026